UPDATE: EraGen CEO Steps Down, Co. Appoints COO | GenomeWeb

This story has been updated from a previous version. 

NEW YORK, Feb 22 - EraGen Biosciences of Alachua, Fla., said Thursday its CEO and president, Gideon Shapiro, stepped down in order to pursue other activities. 

Shapiro said it was “a mutual decision for a new direction the company will be pursuing that needs new expertise.”

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

At Wired, a science journalist discusses her decision not to undergo BRCA testing.

The Japan Times says regulations are needed to oversee human genome-editing research.

In PNAS this week: mutations linked to nasopharyngeal carcinoma, salivary proteins common among oral squamous cell carcinoma patients, and more.

In PLOS this week: molecular surveillance of S. Typhi, genome-wide association study of attention in children, and more.